Issue Date: March 29, 2010
Pfizer, GSK Join Vaccine Alliance
GlaxoSmithKline and Pfizer are the first two companies to commit to providing vaccines against pneumococcal disease to the GAVI Alliance, a public-private health partnership. The two companies will each supply 30 million doses per year over 10 years. GAVI will make the vaccines available at low cost in developing countries, where the disease is a leading cause of death among young children. The supply agreements are part of an . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society